» Articles » PMID: 26752722

Essential Contribution of CD4+ T Cells to Antigen-Induced Nasal Hyperresponsiveness in Experimental Allergic Rhinitis

Overview
Journal PLoS One
Date 2016 Jan 12
PMID 26752722
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Nasal hyperresponsiveness (NHR) is a characteristic feature of allergic rhinitis (AR); however, the pathogenesis of NHR is not fully understood. In this study, during the establishment of an experimental AR model using ovalbumin-immunized and -challenged mice, augmentation of the sneezing reaction in response to nonspecific proteins as well as a chemical stimulant was detected. Whether NHR is independent of mast cells and eosinophils was determined by using mast cell- and eosinophil-deficient mice. NHR was suppressed by treatment with anti-CD4 antibody, suggesting the pivotal contribution of CD4+ T cells. Furthermore, antigen challenge to mice to which in vitro-differentiated Th1, Th2, and Th17 cells but not naïve CD4+ T cells had been adoptively transferred led to the development of equivalent NHR. Since antigen-specific IgE and IgG were not produced in these mice and since antigen-specific IgE-transgenic mice did not develop NHR even upon antigen challenge, humoral immunity would be dispensable for NHR. CD4+ T cells play a crucial role in the pathogenesis of AR via induction of NHR, independent of IgE-, mast cell-, and eosinophil-mediated responses.

Citing Articles

α7 nicotinic acetylcholine receptor agonist attenuates allergen-induced immediate nasal response in murine model of allergic rhinitis.

Yamashita S, Miura K, Matsuura A, Yamasaki N, Uda N, Ogata S J Vet Med Sci. 2024; 86(7):824-827.

PMID: 38839347 PMC: 11251814. DOI: 10.1292/jvms.24-0033.


Modulating asthma-COPD overlap responses with IL-17 inhibition.

do Nascimento Camargo L, Righetti R, de Almeida F, Dos Santos T, Fukuzaki S, Martins N Front Immunol. 2023; 14:1271342.

PMID: 37965351 PMC: 10641519. DOI: 10.3389/fimmu.2023.1271342.


Expression of Concern: Essential Contribution of CD4+ T Cells to Antigen-Induced Nasal Hyperresponsiveness in Experimental Allergic Rhinitis.

PLoS One. 2023; 18(1):e0279797.

PMID: 36630363 PMC: 9833536. DOI: 10.1371/journal.pone.0279797.


Suppressive Effect of subsp. YRC3780 on a Murine Model of Japanese Cedar Pollinosis.

Uchida K, Iida K, Fujioka I, Hachimura S, Kaminuma O Pathogens. 2022; 11(11).

PMID: 36422599 PMC: 9698324. DOI: 10.3390/pathogens11111347.


Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment.

Ueda S, Miura K, Kawasaki H, Ogata S, Yamasaki N, Miura S Biomolecules. 2022; 12(5).

PMID: 35625602 PMC: 9138412. DOI: 10.3390/biom12050674.


References
1.
Cameron L, Hamid Q, Wright E, Nakamura Y, Christodoulopoulos P, Muro S . Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure. J Allergy Clin Immunol. 2000; 106(1 Pt 1):46-52. DOI: 10.1067/mai.2000.107398. View

2.
Bouley J, Groeme R, Le Mignon M, Jain K, Chabre H, Bordas-Le Floch V . Identification of the cysteine protease Amb a 11 as a novel major allergen from short ragweed. J Allergy Clin Immunol. 2015; 136(4):1055-64. DOI: 10.1016/j.jaci.2015.03.001. View

3.
Saito H, Howie K, Wattie J, Denburg A, Ellis R, Inman M . Allergen-induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitis. Immunology. 2001; 104(2):226-34. PMC: 1783291. DOI: 10.1046/j.1365-2567.2001.01253.x. View

4.
Baraniuk J . Mechanisms of allergic rhinitis. Curr Allergy Asthma Rep. 2002; 1(3):207-17. DOI: 10.1007/s11882-001-0007-5. View

5.
Ogawa K, Kaminuma O, Kikkawa H, Nakata A, Asahina M, Egan R . Transient contribution of mast cells to pulmonary eosinophilia but not to hyper-responsiveness. Clin Exp Allergy. 2002; 32(1):140-8. DOI: 10.1046/j.0022-0477.2001.01248.x. View